STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Haemonetics Corporation (NYSE: HAE) has announced the availability of its fourth quarter and fiscal year 2025 financial results, which ended March 29, 2025, on its Investor Relations website. The company will host a conference call and webcast with investors and analysts on May 8, 2025, at 8:00 a.m. ET to discuss the results.

The company has provided access to supplemental materials including the earnings release and tables supporting fiscal 2026 total Company and Hospital reported and organic revenue growth guidance. A replay of the conference call will be available for one year starting May 8, 2025, at 11:00 a.m. ET.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Financial release accessible online

BOSTON, May 8, 2025 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are available on its Investor Relations website.

The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 8, 2025. The conference call and webcast can be accessed with the following information:

In addition, the Company has posted to its Investor Relations website the earnings release and certain supplemental tables that will be referenced during the call and include additional information supporting fiscal 2026 total Company and Hospital reported and organic revenue growth guidance.

Direct link to 4Q FY25 Earnings Release:
https://haemonetics.gcs-web.com/static-files/89295437-34ea-473c-ae6e-409a07328239

Direct link to Hospital Reported and Organic Revenue Growth Guidance Supplemental Tables:
https://haemonetics.gcs-web.com/static-files/320de990-2769-4b30-beca-eff1ca68bad1 

A replay of the conference call and webcast will be available for one year beginning on May 8, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:                                                     


Olga Guyette, Vice President-Investor Relations & Treasury         

David Trenk, Manager-Investor Relations

(781) 356-9763                                                                           

(203) 733-4987

olga.guyette@haemonetics.com                                     

david.trenk@haemonetics.com                                                                               

 

Media Contact:         
Josh Gitelson, Sr. Director-Global Communications      
(781) 356-9776
josh.gitelson@haemonetics.com


Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-4th-quarter-and-fiscal-year-2025-earnings-release-available-on-investor-relations-website-302449085.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) report Q4 and FY 2025 earnings?

Haemonetics will host its Q4 and FY 2025 earnings conference call on May 8, 2025, at 8:00 a.m. ET.

How can I access Haemonetics (HAE) Q4 2025 earnings call?

Investors can access the earnings call through registration at the provided teleconference link or view the live webcast on Haemonetics' investor relations website.

How long will Haemonetics (HAE) Q4 2025 earnings call replay be available?

The replay of the conference call and webcast will be available for one year beginning on May 8, 2025, at 11:00 a.m. ET.

What supplemental materials has Haemonetics (HAE) provided for Q4 2025 earnings?

Haemonetics has provided the earnings release and supplemental tables that include information supporting fiscal 2026 total Company and Hospital reported and organic revenue growth guidance.
Haemonetics Corp Mass

NYSE:HAE

HAE Rankings

HAE Latest News

HAE Latest SEC Filings

HAE Stock Data

3.92B
46.23M
1.15%
115.65%
7.61%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
BOSTON